Biotech Values

[iwfal]

I might need to re-evaluate when the new anti-coags overtake the vit k antagonists?:

The Inquirer noted that Pradaxa exceeded all other medications in the categories of total adverse reports (3,781), deaths (542), hemorrhage (2,367), acute renal failure (291), and stroke (644). In contrast, there were only 731 reports of hemorrhage and 72 deaths associated with Coumadin

.


http://www.prweb.com/releases/pradaxa/death/prweb9585525.htm